Covington Pharmaceuticals: Net profit is expected to increase by 576.45% year-on-year in the first half of 2025.

Coxing Pharmaceuticals announced that its operating income in the first half of 2025 was 700 million yuan, a decrease of 7.82% year-on-year. Net profit was 80.3445 million yuan, an increase of 576.45% year-on-year. Basic earnings per share was 0.41 yuan/share, an increase of 578.63% year-on-year.